Recorded August 18, 2020 | On-Demand Webinar
This session will address general regulatory requirements for bringing a medical product to market under emergency use authorities in the Federal Food, Drug, and Cosmetic Act.
This session was recorded as part of FDLI’s virtual course, "COVID-19: Introduction to FDA’s Existing Legal Authorities and Emerging Issues" in August 2020.